Dr. Hage is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8536 Wilshire Blvd Fl 3
Beverly Hills, CA 90211Phone+1 310-248-8300Fax+1 310-248-8333
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Cardiovascular Disease, 1990 - 1991
- Wright State UniversityResidency, Internal Medicine, 1988 - 1989
- Wright State UniversityResidency, Internal Medicine, 1987 - 1987
- Catholic University of LeuvenClass of 1980
Certifications & Licensure
- CA State Medical License 1989 - 2027
- OH State Medical License 1990 - 1994
- IL State Medical License 1988 - 1990
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Super Doctor SuperDoctors.com
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy Start of enrollment: 2012 Jun 26
- An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension Start of enrollment: 2013 Sep 11
- Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument Start of enrollment: 2013 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- SOPRANO: Macitentan in patients with pulmonary hypertension following left ventricular assist device implantation.Robert P Frantz, Shashank S Desai, Gregory Ewald, Veronica Franco, Antoine Hage
Pulmonary Circulation. 2024-10-01 - The ALPHA phase 1 study: pulmonary ArteriaL hypertension treated with CardiosPHere-Derived allogeneic stem cells.Michael I Lewis, Shelley Shapiro, Ronald J Oudiz, Mamoo Nakamura, Dael Geft
Ebiomedicine. 2024-02-01 - Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension.Ekkehard Grünig, Franck Rahaghi, Jean Elwing, Carmine Dario Vizza, Joanna Pepke-Zaba
Advances in Therapy. 2024-02-01
Press Mentions
- Angioplasty May Be Feasible for Liver Transplantation Candidates with Heart DiseaseJune 22nd, 2011
Professional Memberships
- Member
Other Languages
- Arabic, French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: